BIOAGE LABS INC (BIOA) Stock Analyst Ratings
NASDAQ:BIOA - Nasdaq - US09077V1008 - Common Stock - Currency: USD
ChartMill assigns a Buy % Consensus number of 47% to BIOA. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 5.78. This target is 39.61% above the current price.
BIOA was analyzed by 9 analysts. The buy percentage consensus is at 47. So analysts seem to be rather neutral about BIOA.
In the previous month the buy percentage consensus was at a similar level.
BIOA was analyzed by 9 analysts. More opinions would make the average more meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-03-24 | Citigroup | Maintains | Neutral -> Neutral |
| 2025-02-28 | William Blair | Initiate | Market Perform |
| 2024-12-09 | Citigroup | Downgrade | Buy -> Neutral |
| 2024-12-09 | Jefferies | Downgrade | Buy -> Hold |
| 2024-10-21 | Morgan Stanley | Initiate | Overweight |
| 2024-10-21 | Citigroup | Initiate | Buy |
| 2024-10-21 | Jefferies | Initiate | Buy |